Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES CIPLA DIVIS LABORATORIES/
CIPLA
 
P/E (TTM) x 66.0 32.2 204.7% View Chart
P/BV x 7.1 5.2 138.3% View Chart
Dividend Yield % 0.9 0.6 153.5%  

Financials

 DIVIS LABORATORIES   CIPLA
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-23
CIPLA
Mar-23
DIVIS LABORATORIES/
CIPLA
5-Yr Chart
Click to enlarge
High Rs4,6411,185 391.6%   
Low Rs2,730852 320.4%   
Sales per share (Unadj.) Rs292.6281.9 103.8%  
Earnings per share (Unadj.) Rs68.735.1 195.5%  
Cash flow per share (Unadj.) Rs81.649.7 164.4%  
Dividends per share (Unadj.) Rs30.008.50 352.9%  
Avg Dividend yield %0.80.8 97.5%  
Book value per share (Unadj.) Rs480.9289.2 166.3%  
Shares outstanding (eoy) m265.47807.15 32.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x12.63.6 348.6%   
Avg P/E ratio x53.729.0 185.1%  
P/CF ratio (eoy) x45.220.5 220.1%  
Price / Book Value ratio x7.73.5 217.6%  
Dividend payout %43.724.2 180.5%   
Avg Mkt Cap Rs m978,378822,164 119.0%   
No. of employees `000NANA-   
Total wages/salary Rs m9,75038,301 25.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m77,675227,531 34.1%  
Other income Rs m3,4475,121 67.3%   
Total revenues Rs m81,122232,653 34.9%   
Gross profit Rs m23,69148,079 49.3%  
Depreciation Rs m3,43211,721 29.3%   
Interest Rs m201,095 1.8%   
Profit before tax Rs m23,68640,384 58.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,45312,029 45.3%   
Profit after tax Rs m18,23428,355 64.3%  
Gross profit margin %30.521.1 144.3%  
Effective tax rate %23.029.8 77.3%   
Net profit margin %23.512.5 188.4%  
BALANCE SHEET DATA
Current assets Rs m97,437168,051 58.0%   
Current liabilities Rs m15,33150,333 30.5%   
Net working cap to sales %105.751.7 204.3%  
Current ratio x6.43.3 190.4%  
Inventory Days Days873 11.4%  
Debtors Days Days8427 12,942.6%  
Net fixed assets Rs m51,128117,318 43.6%   
Share capital Rs m5311,614 32.9%   
"Free" reserves Rs m127,140231,845 54.8%   
Net worth Rs m127,671233,460 54.7%   
Long term debt Rs m00-   
Total assets Rs m148,565290,067 51.2%  
Interest coverage x1,209.537.9 3,194.1%   
Debt to equity ratio x00-  
Sales to assets ratio x0.50.8 66.7%   
Return on assets %12.310.2 121.0%  
Return on equity %14.312.1 117.6%  
Return on capital %18.617.8 104.5%  
Exports to sales %85.722.6 378.3%   
Imports to sales %19.88.9 223.0%   
Exports (fob) Rs m66,53751,516 129.2%   
Imports (cif) Rs m15,37820,202 76.1%   
Fx inflow Rs m66,53764,282 103.5%   
Fx outflow Rs m15,71520,202 77.8%   
Net fx Rs m50,82244,080 115.3%   
CASH FLOW
From Operations Rs m24,59732,377 76.0%  
From Investments Rs m-27,076-23,885 113.4%  
From Financial Activity Rs m-7,972-9,583 83.2%  
Net Cashflow Rs m-10,451-968 1,079.8%  

Share Holding

Indian Promoters % 51.9 13.4 386.6%  
Foreign collaborators % 0.0 20.0 -  
Indian inst/Mut Fund % 36.7 50.0 73.5%  
FIIs % 14.9 25.7 57.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 66.5 72.3%  
Shareholders   354,482 425,731 83.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    SUPRIYA LIFESCIENCE     


More on Divis Laboratories vs Cipla

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Divis Laboratories vs Cipla Share Price Performance

Period Divis Laboratories Cipla S&P BSE HEALTHCARE
1-Day 2.14% 1.94% 1.18%
1-Month -2.15% 1.25% -0.75%
1-Year 22.51% 68.02% 61.82%
3-Year CAGR -1.38% 22.53% 18.16%
5-Year CAGR 15.77% 23.24% 19.79%

* Compound Annual Growth Rate

Here are more details on the Divis Laboratories share price and the Cipla share price.

Moving on to shareholding structures...

The promoters of Divis Laboratories hold a 51.9% stake in the company. In case of Cipla the stake stands at 33.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Divis Laboratories and the shareholding pattern of Cipla.

Finally, a word on dividends...

In the most recent financial year, Divis Laboratories paid a dividend of Rs 30.0 per share. This amounted to a Dividend Payout ratio of 43.7%.

Cipla paid Rs 8.5, and its dividend payout ratio stood at 24.2%.

You may visit here to review the dividend history of Divis Laboratories, and the dividend history of Cipla.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.